Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Urate Oxidase

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 9002-12-4, Azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate, Oxidase, urate, Uricase, candida utilis, Mfcd00082126, Ft-0686693
    Molecular Formula
    C18H26N5O14P
    Molecular Weight
    567.4  g/mol
    InChI Key
    VPXDHZMLJOJKOX-UHFFFAOYSA-N
    An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
    2.1.2 InChI
    InChI=1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H,5-6H2,(H,31,32)(H,19,24,29)(H,20,25,30);1H3
    2.1.3 InChI Key
    VPXDHZMLJOJKOX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=CC(=O)NC4=O)CO)O)O.N
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Oxidase, Urate

    2. Urate Oxidase

    3. Uricase

    2.2.2 Depositor-Supplied Synonyms

    1. 9002-12-4

    2. Azane;[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] Hydrogen Phosphate

    3. Oxidase, Urate

    4. Uricase, Candida Utilis

    5. Mfcd00082126

    6. Ft-0686693

    7. Ft-0772402

    8. Uricase From Bacillus Fastidiosus, Lyophilized, ~9 U/mg

    9. Uricase From Arthrobacter Globiformis, Lyophilized Powder, 15-30 Units/mg Protein (biuret)

    10. Uricase From Candida Sp., Recombinant, Expressed In E. Coli, Lyophilized Powder, >=2 Units/mg Solid

    2.3 Create Date
    2007-02-09
    3 Chemical and Physical Properties
    Molecular Weight 567.4 g/mol
    Molecular Formula C18H26N5O14P
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count15
    Rotatable Bond Count8
    Exact Mass567.12138752 g/mol
    Monoisotopic Mass567.12138752 g/mol
    Topological Polar Surface Area255 Ų
    Heavy Atom Count38
    Formal Charge0
    Complexity1070
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count8
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2